{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:14:53Z","timestamp":1789132493261,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Burkitt lymphoma (BL) is a rare disease with the sporadic variant accounting for less than 1% of adult non-Hodgkin lymphomas. BL usually presents with an abdominal bulk, but extranodal disease affecting the bone marrow and central nervous system is common. Cardiac manifestations, however, are exceedingly rare, with less than 30 cases reported in the literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report on a 54-year-old male patient with a six week-long history of paranasal sinus swelling, fatigue and dyspnea on exertion. Stage IV sporadic BL with extensive lymphonodal and cardiovascular involvement was diagnosed. Manifestations included supra- and infradiaphragmatic lymphadenopathy as well as infiltration of the aortic root, the pericardium, the right atrium and the right ventricle. EBV-reactivation was detected, which is uncommon in the sporadic subtype. After initial full-dose chemotherapy with very good BL control, the patient developed acute, but fully reversible cardiac insufficiency. Myocardial lymphoma involvement receded completely during the following two therapy cycles, while cardiac function periodically deteriorated shortly after chemotherapy administration and quickly recovered thereafter. Interestingly, the decline in cardiac function lessened with decreasing myocardial lymphoma manifestation. Once the cardiovascular BL infiltration was resolved, cardiac function remained stable throughout further treatment. Following seven cycles of chemotherapy and mediastinal radiation, the patient is now in continued complete remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although rare, cardiac involvement in BL can quickly become life-threatening due to rapid lymphoma doubling time and should therefore be considered at initial diagnosis. This case suggests an association between myocardial infiltration, chemotherapy associated tumor cell lysis and transient deterioration of cardiac function until the damage caused by the underlying lymphoma could be restored. While additional studies are needed to further elucidate the mechanisms of acute cardiac insufficiency due to lymphoma lysis in the infiltrated structures, prompt BL control and full recovery of the patient supports courageous treatment start despite extensive cardiovascular involvement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02480-5","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:13:54Z","timestamp":1643973234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute left ventricular insufficiency in a Burkitt Lymphoma patient with myocardial involvement and extensive local tumor cell lysis: a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-572X","authenticated-orcid":false,"given":"Maren","family":"Schmiester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tranter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Geisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Kang","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"issue":"1","key":"2480_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood. 2006;107(1):265\u201376.","journal-title":"Blood"},{"issue":"12","key":"2480_CR2","first-page":"1397","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60(12):1397\u2013402.","journal-title":"J Clin Pathol"},{"issue":"3","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pbc.22047","volume":"53","author":"SM Mbulaiteye","year":"2009","unstructured":"Mbulaiteye SM, Biggar RJ, Bhatia K, Linet MS, Devesa SS. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992\u20132005. Pediatr Blood Cancer. 2009;53(3):366\u201370.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2480_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/ejh.12751","volume":"97","author":"MJ Gordon","year":"2016","unstructured":"Gordon MJ, Danilova O, Spurgeon S, Danilov AV. Cardiac non-Hodgkin\u2019s lymphoma: clinical characteristics and trends in survival. Eur J Haematol. 2016;97(5):445\u201352.","journal-title":"Eur J Haematol"},{"key":"2480_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.12659\/AJCR.899022","volume":"17","author":"O Chan","year":"2016","unstructured":"Chan O, Igwe M, Breburda CS, Amar S. Burkitt lymphoma presenting as an intracardiac mass: case report and review of literature. Am J Case Rep. 2016;17:553\u20138.","journal-title":"Am J Case Rep"},{"issue":"1","key":"2480_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0002-9149(68)90250-6","volume":"22","author":"WC Roberts","year":"1968","unstructured":"Roberts WC, Glancy DL, DeVita VT Jr. Heart in malignant lymphoma (Hodgkin\u2019s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol. 1968;22(1):85\u2013107.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/1097-0142(19820301)49:5<944::AID-CNCR2820490519>3.0.CO;2-C","volume":"49","author":"PJ McDonnell","year":"1982","unstructured":"McDonnell PJ, Mann RB, Bulkley BH. Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer. 1982;49(5):944\u201351.","journal-title":"Cancer"},{"issue":"4","key":"2480_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3816\/CLM.2008.n.034","volume":"8","author":"D O'Mahony","year":"2008","unstructured":"O\u2019Mahony D, Peikarz RL, Bandettini WP, Arai AE, Wilson WH, Bates SE. Cardiac involvement with lymphoma: a review of the literature. Clin Lymphoma Myeloma. 2008;8(4):249\u201352.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"6","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"26","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer D, Walewski J, D\u00f6hner H, Viardot A, Hiddemann W, Spiekermann K, et al. Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014;124(26):3870\u20139.","journal-title":"Blood"},{"issue":"10","key":"2480_CR11","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104(10):3009\u201320.","journal-title":"Blood"},{"issue":"3","key":"2480_CR12","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/MPH.0000000000001327","volume":"41","author":"A Koca Yozgat","year":"2019","unstructured":"Koca Yozgat A, Ozyoruk D, Kacar D, Cetin II, Yaman Bajin I, Inan K, et al. Burkitt lymphoma presenting with intracardiac mass and tumor thrombosis in the anterior mediastinum with literature review. J Pediatr Hematol Oncol. 2019;41(3):e197\u2013200.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2480_CR13","doi-asserted-by":"crossref","unstructured":"Vila\u00e7a A, Monteiro M, Pimentel T, Marques H. Intracardiac mass from Burkitt's lymphoma in an immunocompromised patient: a very rare form of presentation. BMJ Case Rep. 2017;2017.","DOI":"10.1136\/bcr-2017-221001"},{"issue":"1","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radcr.2016.11.020","volume":"12","author":"L Cadavid","year":"2017","unstructured":"Cadavid L, Sastoque JM, Guti\u00e9rrez C, Yabur M, Molina G. Primary osseous Burkitt lymphoma with nodal and intracardiac metastases in a child. Radiol Case Rep. 2017;12(1):185\u201390.","journal-title":"Radiol Case Rep"},{"issue":"3","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/17843286.2016.1175703","volume":"72","author":"DM Vervloet","year":"2017","unstructured":"Vervloet DM, De Pauw M, Demulier L, Vercammen J, Terryn W, Steel E, et al. Aggressive extensive cardiac mass in an HIV-1-infected patient: should we go for comfort therapy? Acta Clin Belg. 2017;72(3):198\u2013200.","journal-title":"Acta Clin Belg"},{"key":"2480_CR16","first-page":"687598","volume":"2014","author":"D Tzachanis","year":"2014","unstructured":"Tzachanis D, Dewar R, Luptakova K, Chang JD, Joyce RM. Primary cardiac burkitt lymphoma presenting with abdominal pain. Case Rep Hematol. 2014;2014:687598.","journal-title":"Case Rep Hematol."},{"key":"2480_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1749-8090-2-30","volume":"2","author":"P Kaul","year":"2007","unstructured":"Kaul P, Javangula K. Burkitt lymphoma masquerading as cardiac tamponade. J Cardiothorac Surg. 2007;2:30.","journal-title":"J Cardiothorac Surg"},{"key":"2480_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","volume":"218","author":"A Iqubal","year":"2019","unstructured":"Iqubal A, Iqubal MK, Sharma S, Ansari MA, Najmi AK, Ali SM, et al. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci. 2019;218:112\u201331.","journal-title":"Life Sci"},{"issue":"4","key":"2480_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","volume":"22","author":"VB Pai","year":"2000","unstructured":"Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf. 2000;22(4):263\u2013302.","journal-title":"Drug Saf"},{"issue":"1","key":"2480_CR20","first-page":"140","volume":"117","author":"JA Jackson","year":"1984","unstructured":"Jackson JA, Reeves JP, Muntz KH, Kruk D, Prough RA, Willerson JT, et al. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Am J Pathol. 1984;117(1):140\u201353.","journal-title":"Am J Pathol"},{"issue":"3","key":"2480_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0192-0561(87)90061-0","volume":"9","author":"TA Abdul Hamied","year":"1987","unstructured":"Abdul Hamied TA, Parker D, Turk JL. Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTA Z 7557 (INN mafosfamide) on the release of IL-2 and IL-1 in vitro. Int J Immunopharmacol. 1987;9(3):355\u201361.","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"2480_CR22","first-page":"54","volume":"46","author":"MJ Ehrke","year":"1986","unstructured":"Ehrke MJ, Maccubbin D, Ryoyama K, Cohen SA, Mihich E. Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice. Cancer Res. 1986;46(1):54\u201360.","journal-title":"Cancer Res"},{"issue":"8","key":"2480_CR23","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","volume":"18","author":"BE Levis","year":"2017","unstructured":"Levis BE, Binkley PF, Shapiro CL. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol. 2017;18(8):e445\u201356.","journal-title":"Lancet Oncol"},{"key":"2480_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.biopha.2018.08.035","volume":"107","author":"R Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es R, Silva LM, Cruz ALVM, Fraga VG, de Paula SA, Gomes KB. Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: a narrative review. Biomed Pharmacother. 2018;107:989\u201396.","journal-title":"Biomed Pharmacother"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02480-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02480-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02480-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T23:03:43Z","timestamp":1644015823000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02480-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02480-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}